BioSpace News Archive

New Patent Strengthens the Company’s Robust Cotton Genotyping and Traceability Patent Portfolio

All existing backers including Lux Capital, The Column Group, and Polaris Partners joined by new investors Euclidean Capital and Two Sigma Ventures

Delivered record quarterly net revenues of $53.7 million, representing 77 percent growth versus December 31, 2016, and 7 percent growth versus September 30, 2017

Payoff in Cash of Outstanding Secured Promissory Note with SBI Investments, LLC also Releases Lien on Company’s Beyond Human® Assets and the Related Revenues

MabSpace Biosciences announces on February 16th, 2018 FDA cleared Investigational New Drug (IND) for MSB2311, a humanized programmed death protein-ligand 1 (PD-L1) antibody for the treatment of patients with locally advanced/metastatic solid tumors.

Leading Medical Affairs–Focused Provider of Medical Communications to be Growth Platform

Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers evaluated the performance of noninvasive hemodynamic monitoring (NIHM) using Masimo noninvasive and continuous hemoglobin (SpHb®), as compared to invasive laboratory hemoglobin (LabHb) monitoring, in clinically stable pediatric trauma patients with solid organ injury

Planet Innovation, a leading healthtech product design and commercialization company, today announced a partnership with Preora Healthcare Inc., pioneers in the detection of early-stage cancers, to bring to market a series of novel, low-cost, minimally invasive, highly accurate and easy-to-use cancer screening tests.

NN, Inc., (NASDAQ: NNBR) a diversified industrial company, today announced it has completed the acquisition of the assets of Bridgemedica, LLC (“Bridgemedica”), a medical device company that provides concept to supply solutions through design, development engineering and manufacturing.